Tag: AHA 2022
Rates of all-cause death align between invasive and conservative strategies in ISCHEMIA-EXTEND
Extended follow-up of...
BRIGHT-4 trial: Bivalirudin cuts 30-day mortality for STEMI patients undergoing PCI compared to heparin
Bivalirudin is a safer an...
